Matinas BioPharma Holdings MTNB
NYSE MTNB
$0.19 -0.05 (-20.83%)
At close: Aug 20, 2026 · 4:00 PM EDT

Matinas BioPharma Holdings (MTNB) EPS (Basic) (2014 - 2026)

Matinas BioPharma Holdings (MTNB) posted quarterly EPS (Basic) of -$0.3 for Q1 2026, up 7.89% year-over-year from -$0.28 in Q1 2025, and up 68.7% quarter-over-quarter from -$0.96 in Q4 2025.

Matinas BioPharma Holdings (MTNB) EPS (Basic) (2014 - 2026) Analysis & Trends

Matinas BioPharma Holdings (MTNB) has reported EPS (Basic) for 13 consecutive years, with -$0.3 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 7.89% year-over-year to -$0.3; the TTM figure through Mar 2026 stood at -$1.78 (up 62.33% YoY), while the FY2025 annual figure was -$2.0, up 59.82% from the prior year.
  • EPS (Basic) improved to -$0.3 in Q1 2026 per MTNB's latest filing, from -$0.96 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.3 in Q1 2026 and bottomed at -$1.95 in Q2 2024.
  • Historically, EPS (Basic) has averaged -$1.15 across 5 years, with a median of -$1.36 in 2023.
  • Annual changes were most pronounced in 2023 — EPS (Basic) sank 61.66% — and 2025, when it surged 79.33%.
  • Matinas BioPharma Holdings' EPS (Basic) stood at -$0.84 in 2022, then slumped by 61.66% to -$1.36 in 2023, then decreased by 27.9% to -$1.73 in 2024, then surged by 44.72% to -$0.96 in 2025, then jumped by 68.7% to -$0.3 in 2026.
  • Business Quant data shows MTNB's EPS (Basic) at -$0.3 in Q1 2026, -$0.96 in Q4 2025, and -$0.4 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.62
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.59
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.23
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.18
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Matinas BioPharma Holdings 1.19 Mn 375,426.61 - -0.21

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.21
Mar 31, 2026 -0.30
Dec 31, 2025 -0.96
Sep 30, 2025 -0.40
Jun 30, 2025 -0.41
Mar 31, 2025 -0.33
Dec 31, 2024 -1.73
Sep 30, 2024 -0.85
Jun 30, 2024 -1.95
Mar 31, 2024 -1.57
Dec 31, 2023 -1.36
Sep 30, 2023 -1.65
Jun 30, 2023 -1.66
Mar 31, 2023 -1.53
Dec 31, 2022 -0.84
Sep 30, 2022 -1.26
Jun 30, 2022 -1.37
Mar 31, 2022 -1.38
Dec 31, 2021 -1.59
Sep 30, 2021 -1.59